• Home
  • Policy for Anti-Discrimination

Policy for Anti-Discrimination

Policy for Anti-Discrimination

Policy for Anti-Discrimination

Approved Board of Management on 12th January 2019
Notification Notified by Registrar vide notification No. SRHU/Reg/OO/2019-04 (i) dated 15th January 2019
Reviewed / Revised Board of Management on 29th March 2022
Notification Notified by Registrar vide notification No. SRHU/Reg/OO/2022-58 (i) dated 5th April 2022
Next Review 2025–26
  • 1. Short Title & Commencement
    • 1.1 This Policy shall be called the “Policy for Anti-Discrimination” of Swami Rama Himalayan University.
    • 1.2 This Policy shall be deemed to have come into force from the date of approval of the Board of Management of the University.
  • 2. Purpose To ensure a workplace free from discrimination, where all individuals are treated fairly, respectfully, and equitably regardless of their gender, caste, ethnicity, religion, age, disability, sexual orientation, or any other protected characteristic.
    • 2.1.1 Reduce inequality within and among countries.
    • 2.1.2 Promote inclusive and equitable employment practices.
    • 2.1.3 Foster a diverse and respectful organizational culture.
  • 3. Scope This policy applies to:
    • 3.1 All employees (permanent, contractual, probationary, interns, and part-time).
    • 3.2 All applicants for employment.
    • 3.3 All employment-related activities, including recruitment, promotions, training, compensation, benefits, and termination.
  • 4. Goals The policy goals are to:
    • 4.1 Equal Opportunity: All employees and applicants are entitled to fair treatment in all employment processes.
    • 4.2 Non-Discrimination: No individual shall face discrimination based on:
      • 4.2.1 Gender, sexual orientation, or gender identity.
      • 4.2.2 Race, caste, ethnicity, or religion.
      • 4.2.3 Age, disability, marital or family status.
      • 4.2.4 Political affiliation, social background, or other protected characteristics.
    • 4.3 Merit-Based Decisions: Employment, promotions, and benefits are based solely on skills, qualifications, and performance.
    • 4.4 Zero Tolerance for Harassment: Harassment, bullying, or any form of unfair treatment is strictly prohibited.
  • 5. Implementation Measures
    • 5.1 Recruitment and Hiring
      • 5.1.1 Ensure transparent and bias-free recruitment processes.
      • 5.1.2 Use inclusive job descriptions and standardized evaluation criteria.
    • 5.2 Promotions and Compensation
      • 5.2.1 Base promotions and salary adjustments on objective performance metrics.
      • 5.2.2 Conduct regular pay equity reviews to prevent wage disparities.
    • 5.3 Training and Awareness
      • 5.3.1 Conduct diversity, equity, and inclusion training for all employees and managers.
      • 5.3.2 Raise awareness about unconscious bias and fair workplace practices.
    • 5.4 Grievance Mechanism
      • 5.4.1 Establish confidential reporting channels for discrimination complaints.
      • 5.4.2 Investigate all complaints promptly, fairly, and impartially.
      • 5.4.3 Protect complainants and witnesses from retaliation.
    • 5.5 Monitoring and Reporting
      • 5.5.1 Maintain records of employment, promotions, pay, and complaints disaggregated by key demographics.
      • 5.5.2 Conduct annual audits to ensure compliance with non-discrimination standards.
  • 6. This policy shall be reviewed every three years or earlier if required to accommodate new educational practices, regulatory requirements, or emerging student needs.
  • 7. The University reserves the right to interpret, alter, amend, modify, cancel, or withdraw any or all provisions mentioned herein without notice.
  • 8. In case of any dispute, the decision of the Vice Chancellor of the University shall be final and binding.
   Admissions Form         

Admission Open For 2025

×
International Endowed Chair Professor

Prof Rakesh Kumar

Prof Rakesh Kumar is the Founder and President of the Breast Cancer in Young Women Foundation (USA), dedicated to vaddressing the distinct issues affecting young women with breast cancer. He also serves as the International Endowed Chair Professor at the Cancer Research Institute of the Himalayan Institute of Medical Sciences. Additionally, he holds adjunct professorships at Rutgers New Jersey Medical School and Virginia Commonwealth University.

Dr Kumar earned his Ph.D. from the All India Institute of Medical Sciences in 1984 and began his research career at Memorial Sloan Kettering Cancer Center in January 1986. From 1988 to 2017, he held various academic and leadership positions —including faculty member, tenured professor, distinguished professor, endowed chair, department chair, and research leader—at esteemed institutions such as Memorial Sloan Kettering Cancer Center in New York and the University of Texas MD Anderson Cancer Center in Houston. From 2017 to 2022, he served as the National Chair for Cancer Research for the Government of India and as a distinguished professor, continuing his innovative work in breast cancer research.

With nearly 40 years of research and professional experience, Dr. Kumar has made conceptual contributions to the field of cancer research (h-index 108, citations >50,000). He has authored over 325 peer-reviewed publications, edited or co-edited nine books, and delivered 290 invited lectures worldwide. His work has been featured on the covers of 18 major cancer journals and has been highlighted in institutional research reports of the MD Anderson Cancer Center.

A passionate educator and mentor, Dr. Kumar has guided 67 trainees throughout his career. He serves on the editorial boards of multiple leading cancer journals and has served on the editorial boards of 21 top cancer journals. His global reputation is further demonstrated by his participation in about 100 peer-review panels for cancer research funding in the US and internationally over the past 28 years.

Dr. Kumar's innovative research has earned him numerous prestigious honors, including the Hinkle Society Faculty Award at Penn State University (1994), the Dalla/Fort Worth Living Legend Faculty Achievement Award in Basic Sciences (2004), the Ranbaxy Research Award (2006), and the Lifetime Achievement Award from the American Association of Indian Scientists in Cancer Research (2013), among others. Dr. Kumar's pioneering research continues to have a profound influence on the fields of oncology and breast cancer, opening up new opportunities for biomedical scientists and trainees worldwide.